Zdrowie i gospodarka · 18/01/2023
FDA Clears OFIRMEV (Acetaminophen) Injection for Approval
The US Food and Drug Administration has determined that OFIRMEV acetaminophen injection, 1,000 mg/100 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential FDA approval of the drug.
Source: Federal Register — Food and Drug AdministrationOpen original release →